Navigation Links


Erectile at Biology News

Study of gene transfer for erectile dysfunction shows promise

The first human study using gene transfer to treat erectile dysfunction (ED) shows promising results and suggests the potential for using the technology to treat overactive bladder, irritable bowel syndrome and asthma, according to the researchers. "In the small pilot study, this new therapy was well tolerated and safe," said George Christ, Ph.D., senior researcher and a professor at the I...

'Erectile dysfunction' drugs heighten natural anti-cancer activity

Sildenafil and other "impotence drugs" that boost the production of a gassy chemical messenger to dilate blood vessels and produce an erection now also show promise in unmasking cancer cells so that the immune system can recognize and attack them, say scientists at the Johns Hopkins Kimmel Cancer Center. Tests at Hopkins on mice with implanted colon and breast tumors showed that tumor size...

Erectile dysfunction in diabetes is due to selective defect in the brain

A new study sheds additional light on how erectile dysfunction (ED) interacts with diabetes. The study is another step in uncovering the link between the two disorders, and may lead to improved efficacy in treatments. The study, "Lack of Central Nitric Oxide Triggers Erectile Dysfunction in Diabetes," was conducted by Hong Zheng, William G. Mayhan, and Kaushik P. Patel, Departments of Cel...

Gene therapy delivery of nerve growth factors reverses erectile dysfunction in animal model

Rats with erectile dysfunction, or ED, that were injected with a gene therapy vector containing either of two nerve growth factors were able to regain normal function after four weeks, according to a study conducted by University of Pittsburgh School of Medicine researchers. These findings are being presented at the 10th annual meeting of the American Society of Gene Therapy, which is convenin...
Erectile at Biology Products
Erectile at Biology Technology
Erectile at Medicine News

Second hope for men with erectile dysfunction

Pfizer's Viagra was a blessing in disguise for the over 150 million around the world who silently suffered from the male sexual disorder called erectile dysfunction. Now, these men have a second hope with two new drugs introduced(and waiting for approval from the U.S. FDA) by the drug majors Eli Lilly and Bayer. The drugs, Cialis (tadalafil), by Eli Lilly, and Levitra (vardenafil), by Bayer, are...

Erectile dysfunction (ED) signals vascular disease

Erectile dysfunction, a problem few men discuss with their physicians, can be an early warning sign of cardiovascular disease. Risk factors associated with cardiovascular disease, hypertension, diabetes, high cholesterol, obesity and smoking are the same as those associated with impotence. It is estimated that Erectile dysfunction affects 40 million men, yet just 10 percent seek treatment, partly...

An Exploration into Erectile Dysfunction in Diabetics

An over-supply of a simple blood sugar could be a major cause of erectile dysfunction in diabetic men according to a new study. It has been found that one particular simple sugar, present in increased levels //in diabetics O-GlcNAc, interferes with the chain of events needed to achieve and maintain erection and can lead to permanent penile impairment over time. The findings could have...

Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?

Erectile dysfunction (ED) is the inability of a man to achieve or maintain an erection sufficient for his sexual needs or the needs of his partner. Most men experience this at some point in their lives//, usually by age 40, and are not psychologically affected by it. Some men, however, experience chronic, complete ED (impotence), and often leads to diminished self-esteem. According to a...

Erectile Dysfunction Drug Viagra Launched In India By Pfizer

The most popular drug Viagra has been launched by the pharmaceutical company Pfizer in 30 different cities across India where more than 90 million men are believed to suffer from erectile dysfunction.// The drug company is expected to gain access to approximately 10 to 15 % of the market within the next two years according to K.G. Ananthakrishnan, senior director of drug company in charge of the...

More>>

Erectile at Medicine Products
Erectile at Medicine Technology

Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide

CRANBURY, N.J., and BRISTOL, Tenn., May 22, 2007/PRNewswire-FirstCall/ -- Palatin Technologies, Inc. and KingPharmaceuticals, Inc. reported today that data from Study 16 andStudy 17 of the Phase 2B clinical trial program evaluatingbremelanotide in men with erectile dysfunction (ED) were presentedyesterday at the American Urological Association (AUA) AnnualMeeting (AUA 2007) held in Anahe...

Palatin Technologies and King Pharmaceuticals Announce Plan To Present Results of Bremelanotide Phase 2b Studies in Men With Erectile Dysfunction

CRANBURY, N.J. and BRISTOL, Tenn., May 09, 2007/PRNewswire-FirstCall/ -- Palatin Technologies, Inc. and KingPharmaceuticals, Inc. today announced plans to present the resultsfrom two bremelanotide Phase 2b studies of men with erectiledysfunction (ED). The presenters are Jed Kaminetsky, MD, ClinicalAssistant Professor, Department of Urology, NYU School of Medicine;Stanley E. Althof, PhD,...

Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil, Its New Long Acting Drug For Erectile Dysfunction

All Endpoints Met - Up to 88% Efficacy SEOUL, Korea, March 28, 2007 /PRNewswire/ -- Dong-A PharmTechCo., Ltd. announced today that it has completed a 340 patient phase2b "at-home" clinical study for udenafil, its new long acting (12hour half-life) oral phosphodiesterase type 5 (PDE5) inhibitor forerectile dysfunction (ED). The multi-center study conducted in theU.S. was a randomized, doub...
Other TagsManagemeManagemeManagemeManagemeManagemeGrips
(Date:8/20/2008)... on bisphenol A evaluation, FALLS CHURCH, Va., Au...cians, and children,s health advocates expressed o...A) announcement that bisphenol A - the hormone,dis...ts including can,linings and baby bottles - is "sa...ked to obesity, developmental problems, risk for h...
(Date:8/20/2008)...e/ -- The National Institutes of,Health estimates .... For at,least half of these headaches sufferers, ...sabling. If headaches cause disruptions in your li...o: http://www.newscom.com/cgi-bin/prnh/20080415/N...od vessels outside of your skull,put pressure on y...
(Date:8/20/2008)...re, a high-speed dental air unit designed for vete...inary. , Louisville, KY (...r http://www.dreveterinary.com/index.php [veteri...-Aire, a mobile http://www.dreveterinary.com/prod...rinary dental cart]. It comes fully-equipped with ...
(Date:8/20/2008)...hnologies, AggreWell™400 plate is a novel to...ryoid bodies. , Vancouver...p://www.stemcell.com [STEMCELL Technologies], a l...tion products and ancillary reagents for stem cell...eWell™400 plates, a revolutionary tool for r...
Breaking Medicine News(10 mins):Health News:FDA Decision on BPA Outrages Health Advocates 2Health News:FDA Decision on BPA Outrages Health Advocates 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: To Relieve Headaches, Be Proactive 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: To Relieve Headaches, Be Proactive 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: To Relieve Headaches, Be Proactive 4Health News:Figure Skater Peggy Fleming Teams With HealthSaver: To Relieve Headaches, Be Proactive 5Health News:DRE Veterinary Distributes All-In-One Veterinary Dental Cart 2Health News:DRE Veterinary Distributes All-In-One Veterinary Dental Cart 3Health News:STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research 2
(Date:8/19/2008)... Serpentine soils contain highly variable amounts .... Successful management of serpentine soils requir...Research published this month in the Soil Science...easurement techniques are needed to accurately mea...ake these marginal growing lands productive, farme...
(Date:8/19/2008)... week in the online early edition of the Proceedi...at coal burning, primarily in North America and Eu...cted human health and ecosystems in and around Ear...rning Leaves Toxic Heavy Metal Legacy in the Arcti... (DRI), Reno, Nev. and partially funded by the Nat...
(Date:8/19/2008)... advice to drink enough H2O and not eat too much N... grapefruit, onions, peppers, tomatoes, carrots an...ociety meeting., The world,s largest scientific ...ricultural and Food Chemistry Division with a seri... benefits from phytochemicals in fruits and vegeta...
(Date:8/18/2008)...al Information over Verizon Wireless Network ... WALL, N.J., Aug. 18 /PRNewswire-FirstCall/ -- BI...), a leader in finger-based biometric,identificati...ounced the,recent expansion of a unique, cross-jur...stem utilizing the company,s InfoExchange(R) data,...
Breaking Biology News(10 mins):Greenland ice core reveals history of pollution in the Arctic 2Regional Law Enforcement Data Exchange System Expands 2Regional Law Enforcement Data Exchange System Expands 3Wearable Sensors Conceived at Harvard Robotics Lab Measure Hand Forces 3860 1Wearable Sensors Conceived at Harvard Robotics Lab Measure Hand Forces 3860 2Analysis of cancer incidence mortality and survival combined reveals encouraging European trends 23106 1Analysis of cancer incidence mortality and survival combined reveals encouraging European trends 23106 2Analysis of cancer incidence mortality and survival combined reveals encouraging European trends 23106 3Analysis of cancer incidence mortality and survival combined reveals encouraging European trends 23106 4Analysis of cancer incidence mortality and survival combined reveals encouraging European trends 23106 5Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case 23101 1Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case 23101 2Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case 23101 3SINOL USA Inc and Strategic Pharmaceutical Advisors Inc to Enter a Marketing Agreement for SINOL Nasal Spray 23098 1SINOL USA Inc and Strategic Pharmaceutical Advisors Inc to Enter a Marketing Agreement for SINOL Nasal Spray 23098 2
Other Contentsprostatectomyprostatectomyprostatectomyproteinuriaprostatitispruritusprurituspseudogoutelasticumpseudoxanthoma